Diuretics I & II Flashcards
what are the ions reabsorbed/secreted in the
proximal tubule?
thick ascending loop of henle?
distal convluted tubule?
collected tubule?
- reabsorbed: (note Na, Cl- reabsorbed at each segment)
- proximal tubule: Na+, Cl- HCO3
- thick ascending loop of henle: Na, Cl-, Ca+, Mg
- distal convoluted tubule: Na-, CL- Ca
- collecting tubule: Na, Cl-
- secreted:
- proximal tubule: H+
- collecting tubule: H+, K+
carbonic anhydrase inhibitor diuretics act on what renal tubular segment?
proximal tubule
loop diuretics act on what tubular segment?
thick ascending loop of henle
thiazide diuretics act on what tubular segment?
distal convoluted tubule
K+ sparing diuretics act on what part of the tubular segment?
the collecting tubule




carbonic anhydrase inhibitors
- renal MOA
- MOA: multiple
-
renal: diuresis by acting on the proximal convoluted tubule
- inhibits reabsorption of Na+, HCO3 and HCl-
- recall from phys:
-
Na+/H antiporter takes up Na+ in exchange for H+
- Na+ reabsorbed into blood by Na/K transporter
- the secreted H+ combinates with bicarb to make H2CO3
- H2CO3 dissociates back into back into H2O + CO2 via carbonic anhydrase
- these products are reabsorbed into the cell and ultimately break down to release HCO3 (which is reabsorbed into the blood) and H+, which drives Na+/H antiport
- (antiport necessary to drive Na+ reabsorption)
-
Na+/H antiporter takes up Na+ in exchange for H+
- recall from phys:
- thus, inhibition of carbonic anhydrase impedes both Na+ and HCO3 reabsorption
- since HCO3- starts the accumulate in the filtrate, the filtrate becomes basic.
- the Cl-/base exchanger, which pumps base into the blood in exchange for sodium reabsorption, is now slowed
- this slows Cl- reabsorption
- inhibits reabsorption of Na+, HCO3 and HCl-
-
renal: diuresis by acting on the proximal convoluted tubule

net effects of carbonic anhydrase inhibitors
- decreased reaborption Na, HCO3 and Cl
- net effect:
- reduced NaHCO3 and NaCl reabosprtion
-
increased tubular concentration of NaHCO3 and NaCl, which results in.
- DIURESIS (due to NaCl)
* water follows NaCl into tubule
* increased urine volume –> pee it out
- DIURESIS (due to NaCl)
- INCREASED URINE pH (due to NaHCO3)
- net effect:
why is tolerance to carbonic anhydrase inhibitor diuretics so common?
- in response to basic urine pH resulting from CAIs, the body compensates with metabolic acidosis
- the body provides H+ for the plasma
- the plasma H+ diffuses into the cell, then drives the Na+/H+ antiporter, promoting Na+ reabsoprtion and H+ secretion (which then combines with HCO3-) to ultimately pull it back into the cell
- though carbonic anhydrase can still inhibit CAIs, the Na+/H+ antiporter now works, Na+ enters the blood, followed by water –> high blood pressure

non-renal indications and MOAs of carbonic anhydrase inhibitors
- CAIs used to treat high pressure in the eye and cerospinal system
-
glaucoma
-
in eye - carbonic anhydrase generates HCO3- that draws Na+ and fluid into the aqueous humor
- __this increases the introocular pressure/
- CAIs inhibit this process to lower introular pressure
-
in eye - carbonic anhydrase generates HCO3- that draws Na+ and fluid into the aqueous humor
-
cerebrospinal pressure
- in brain - carbonic anhydrase generates HCO3- that draws inNa+ and fluid into the cerbrospinal fluid
- increases cerobrospinal fluid pressure
- CAIs inhibit this process
- in brain - carbonic anhydrase generates HCO3- that draws inNa+ and fluid into the cerbrospinal fluid
-
glaucoma
_(_dont fully understand the mechanisms here)

clinical uses of CAI
- glaucoma
-
high cerobrospinal pressure
- can also treat acute mountain sickness resulting from high cerocrospinal pressure:
- sickness caused when high cranial pressure impedes oxygen extraction
- CAIs lower pressure and allow for improved O2 intake/CO2 removed
- sickness caused when high cranial pressure impedes oxygen extraction
- can also treat acute mountain sickness resulting from high cerocrospinal pressure:
- urinary acidosis - CAIs increase urinary HCO3
-
compensatory metabolic alkalosis (resulting from excessive use of diuretics or respiratory acidosis)
- CAIs increase urinary HCO3, neutralizing acidic urine so the body doesn’t have to

AEs of CAIs
- metabolic acidosis (CAIs correct urinary acidosis, but resulting urinary alkalosis could induce compensatory metabolic alkalosis)
- renal K+ wasting
-
renal stones (rarely)
- due to K+, Ca+ excretion, these ions forms stones in tubules
- parathesia
- drowsiness
- hypersensitivity reactions

name of CAI
acetazolamine (a sulfonamide)
loop diuretics MOA
loop diuretics act on the thick ascending loop of henle
- here, they inhibit reabsoprtion of Na+, Cl-, Mg+, Ca+
- recall from phys:
- the NKCC2 transporter pumps Na+, K+ and 2Cl- into cell from filtrate
- on basolateral side, the reabsorbed Na+ moves into the blood in exchange for K+ thru Na/K ATPase
- the combined K+ increase in the cell drives K+ out of the cell into the filtrate
- this increases the (+) charge in the filtrate
- this drives cations Mg2+ and Ca2+ out of filtrate into cell –> into blood
- combined reabsorption Na, CL-, Mg and Ca creates medullary hypertonicity
- K+ secreted after initial reabsorption so does not contribute to this
- loop diuretics work by:
- inhibiting the NKCC2 transporter - inhibits all absorption resulting from that transporter (Na, Cl, Mg, Ca)
- reduces medullary tonicity
- inhibiting the NKCC2 transporter - inhibits all absorption resulting from that transporter (Na, Cl, Mg, Ca)
- recall from phys:

overall effects of loop diuretics
- decrease tonicity of medulla
- this diminshes the the osmotic gradient that goes from the cortex to the medulla: typically, the solute reabsorbsion that occurs at the thick ascending limb establishes a interstitial concentration that increases from the cortex down into the medulla and promotes water reabsoprtion in the thin descending limb and collecting tubules
- since loop diruetics inhibit reabsorption at TAL, they disrupt this gradient and impede water reabsorption at the thick descending limb at collecting tuubles
- this diminshes the the osmotic gradient that goes from the cortex to the medulla: typically, the solute reabsorbsion that occurs at the thick ascending limb establishes a interstitial concentration that increases from the cortex down into the medulla and promotes water reabsoprtion in the thin descending limb and collecting tubules

what are the loop diuretics?
- furosemide
- bumetanide
- torsemide
- ethacrynic acid
MOA of thiazide diuretics
thiazide diuretics act at the DCT (distal convoluted tubule)
- at the DCT: Na, Cl, Ca++ reabsorbed
- recall from phys:
- a Na/K ATPase establishes a Na+ gradient that drives NCC, a NaCl cotransporter
- NCC moves Na+ and Cl- from filtrate into cell for reaborption
- a Na/K ATPase establishes a Na+ gradient that drives NCC, a NaCl cotransporter
- recall from phys:
- thiazide diuretics block the NCC channel:
- __this decreases Na+ and Cl- reabsorption
- the decrease in intracellular [Na+] drives a Ca++/Na+ exchanger to move Na+ from the blood into the cell in exchange fro Ca++
- –> increasing Ca++ reabsoprtion
- the decrease in intracellular [Na+] drives a Ca++/Na+ exchanger to move Na+ from the blood into the cell in exchange fro Ca++
- they also may increase Ca++ reabsorption at the PCT as a result of volume depletion
- __this decreases Na+ and Cl- reabsorption

net effects of thiazide diuretics
- increased excretion of NaCl, water, and K+ (?)
- increased reabsorption of of Ca++

contrast the effects of loop diuretics and thiazide diuretics on Ca++ movement and what this means in terms of their clinical uses
have opposite effects:
- loop diuretics: decrease Ca++ reabsorption, increase tubular Ca++
- thus can be used to treat with patients with hypercalcemia [high blood Ca++]
- thiazide diuretics: increase Ca++ reabsorption, lower tubular Ca++
- thus can be used to treat patients hyperuricemia
- this can reduce the risk of gallstones
- thus can be used to treat patients hyperuricemia
contrast loop and thiazide diuretics in terms of potency
loop diuretics more potent

describe how loop and thiazide diuretics can be used to treat “edematous status”
both drugs can be used to lower edema caused by the two following conditions:
-
chronic heart failure (HF)
- HF leads to edema because: lowered CO leads to –> renal hyperperfursion –> riggering RAAS activation –> causing Na+/water reabsorption –> f_luid retention_ –> edema
- both drugs inhibit fluid rention, lowering edema as well as pulmonary and systemic congestion
-
loop vs thiazide:
- loop diuretics best for severe HF and first choice for rapid relief of congestive symptoms
- thiazide diruetics: best for mild HF
- HF leads to edema because: lowered CO leads to –> renal hyperperfursion –> riggering RAAS activation –> causing Na+/water reabsorption –> f_luid retention_ –> edema
-
acute pulmonary edema
- both durgs promote Na+ and water excretion –> lowering ventricular feeling pressure –> decreasing pulmonary edema
-
loop vs thiazide:
- both drugs can be used, loop diuretics are better - “drug of choice” for acute pulmonary edema
describe how loop and thiazide diuretics can be used to manage hypertension.
- Thiazide diuretics: all patients with essential hypertension and normal renal function
- Loop diuretics: hypertensive patients with renal insufficiency or heart failure
discuss use of loop and thiazide diuretics in the treatment of diabetes
only thiazide diuretics are use dto treat diabetes. they can be used to treat
- diabetes insipidus (DI):
- diabetes inspidus is characterize by an inability of ADH to induce water reabsorption, either due to 1. impaired ADH synthesis (neurogenic DI) or 2. inadeuqate response of kidney to ADH
- use of thiazides:
- thiazides relieve polyuria and polydipsia secondary to DI by increasing urine flow (dont really get this, picture attached)
- they are indicated in the treatment of lithium induced nephrogenic DI
- they work by increasing expression of Na+ transporters in the DCT and CCT –> increasing water reabsorption
discuss the clinical uses of thiazide diuretics pertaining to its effect on Ca++ movement
- thiazide diuretics increase Ca++ reabsorption in the DCT and PCT, and can thus be used to treat:
- nephrolithiasis (caused by a defect of Ca++ reaborption in PCT)
- osteoporosis
- hyperuricemia
discuss the clinical use of loop diuretics pertaining to their effect on calcium reabsorption
- loop diuretics decrease Ca++ reabsorption
- they are combined with saline to treat hypercalcemia in patients with:
- renal failure
- HF
- they are combined with saline to treat hypercalcemia in patients with:
thiazide-like duiretics
- what are they?
- what are their clinical uses and how do they work?
- indapamide, metaolazone, chlorthalidone
- can be combined with loop diuretics to treat patients with edema who:
- have a GFR < 20 ml/min
- are refractory to loop diuretics
- how this works:
- since these thiazide like diuretics decrease Na++ reabsorption in the PCT/DCT, they i_ncrease the load of Na++_ in the tubular filtrate in the thick ascending limb. this is Na++ that would have otherwise been reabsorbed, but will now be excreted due to loop diuretics

adverse effects of both loop and thiazide diuretics
hypos:
- hyponatremia
- hypomagnesemia (especially loop diuretics)
-
hypokalemic metabolic acidosis: both diuretics increase tubular Na++ that arives to the collecting ducts
- this may induce aldosterone mediated activativation of the Na/K exchanger, which would promote Na+ uptake in exchange for K+ secretion
hypers:
-
hyperuiciemia: this is because the diuretics themselves are secreted via an organic acid transporter that secretes uric acid.
- the diuretics can compete for this transporter, leading to buildup or uric acid in the blood
-
hyperglycemia
- hypokalemia can cause can decrease insulin secretion from pancreas B-cells
- this doesn’t apply to thiazide-like diuretics
- possibly hyperlipidemia
- allergic reactions
what are the unique AEs of loop diuetics?
otoxicity: reversible, stria vascularis edema that damages the ears
what are the unique adverse effects of thiazide diuretics?
hypercalcemia
drug drug interactions of loop & thiazide diuretics
- dofelitide: prolonged QT interval
- digoxin: hypokalemia
- NSAIDS: decrease diuretic effect
- anti-hypertensives: can cause hypotension
what are the unique functions of the collecting tubule?
- the collecting tubule is:
- the final site of NaCl reabsorption
- action site of ADH and aldosterone
- site of K+ secretion
- and thus the site of diruetic induced K+ changes
discuss the movement of solutes at the collecting tubule
- reabsorption of Na+ in principle cells causes a negative intraluminal charge that drives:
- K+ secretion from principle cells
- paracellular Cl- reabsorption
- H+ secretion from adjacent intercalated cells

what are the classes of K+ sparing diuretics and their MOAs?
- they act on the collecting tubules to
- increase excretion of Na+ and Cl-
- decrease excretion of K+ and H+
- classes: both block reabsorption at Na+ channel
- aldosterone antagonists
- Na+ blockers

list the drugs in each class of K+ sparing diuretics.
- aldosterone receptors antagonists
- spironolactone
- epleronone
- Na+ channel blockers:
- amiloride
- triamterine
what are the clinical uses shared by all K+ sparing diuretics?
- both aldosterone antgonists and Na+ blockers: can be used to treat
- edema and hypertension - in combo w/other diuretics
- nephrogenic DI - in combination with thiazide diuretics
what are the clinical uses of aldosterone receptor antagonists?
spironolactone, epleronone
- hypertension, edema, nephrogenic DI (along with Na+ blockers)
- specific to aldosterone antagonists:
-
hyperolderstonemia
- primary hypersecretion: increased aldosterone secretion
- secondary hypersecretion: caused by reduced intravascular volume
- chronic heart failure with reduced ejection fraction
- edema due to cirrhosis
-
hyperolderstonemia
what are the adverse effects of both aldsterone antagonists and Na+ blocker potassium diuretics?
- hyperkalemia
- metabolic acidosis
what are the adverse effects of aldosterone receptor antagonists?
- hyperkalemia, metabolic acidosis (applies to all K+ sparing diuretics)
- gynecomastia
- mentstural irregularities
- decreased libido
these AEs seen mostly in spironolactone
AEs of triamterine
triamterine = Na+ channel blocke
- hyperkalemia, metabolic acidosis (all k+ sparing diuretics)
- megoblastic anemia
- kidney stones
- acute renal failure
AEs of amiloride?
amiloride = Na+ channel blocker (potassium sparing diuretic)
- hyperkalemia, metabolic acidosis (all K+ sparing diuretics)
- nausea, vomitting, diarrhea
- headache
what are the contraindications of K+ sparing diuretics?
- oral K+ administration
- hyperkalemia
- renal insufficiency
what are the drug drug interactions of K+ sparing diuretics?
- coadministration with the following drugs increases the risk of hyperkalemia:
- __ACE inhibitors/ARBs:
- block RAAS –> decrease aldosterone secretion and thus increase K+ retention
- K+ supplements
- trimethoprine - behaves like an Na+ blocker (sounds like triameterene)
- cyclosporine & tacrolimus - impair K+ excretion
- __ACE inhibitors/ARBs:
potassium binding agents?
- what are they?
- what is their MOA?
- what are their clinical uses?
- drug drug interactions?
- potassium binding agents:
- paritromer (an oral suspension)
- sodium polystyrene sulfonate
- MOA: binds excess K+ in the intestinal lumen –> promotes its excretion
- clinical uses: non life-threatening hyperkalemia
- drug-drug interaction:
- effects absorption of other drugs from the GI tract.
- should be a 3 hr time gap between K+ binding agents and administration of other drugs
mannitol
- how does it work as a diuretic?
- how is it admistered?
- pharmokinetics
- mannitol is an osmotic diuretic
- MOA:
- mannitol is easily filtered through the glomeruli
- is restricted to the extracellular fluid compartment
- thus, is NOT reabsorbed from the tubules
- locally, by increasing osmolality of rental tubular fluid, mananitol
- prevents water reabsorption in the PCT and the descending loop of Henle
- opposes the action of ADH in the collecting tubule
- pharmokinetics:
- not metabolized
- nontoxic
- uses:
clinical uses of mannitol as a diuretic.
- CNS uses:
- cerebral edema
- intracranial hematoma
- glaucoma
- reduces intraocular pressure in patients requiring ocular surgery
- administered pre-and post operation
- reduces intraocular pressure in patients requiring ocular surgery
- prevents anuria (failure of the kidney to produced urine) caused by hemolysis (lysed RBCs) or ryabdomyolysis (muscle breakdown)
adverse effects of mannitol
- can expand the ECF volume to the point of:
- worsening heart failure
- producing pulmonary edema
- causing
- headache
- nausea
- vomitting
- dehydration
- hyperkalemia, hypernatrmia
contraindications of osmotic diuretics
- Pulmonary edema
- Poor cardiac reserve
- Severely dehydrated patient
- Active cranial bleeding (though it can be used to treat intracrnial hemotoma)
- Anuria (though it can be used to prevent anuria)
summarize the drugs within each class of diuretics
